Destiny Wealth Partners, LLC Bristol Myers Squibb CO Transaction History

Destiny Wealth Partners, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 26, 2023	BUY	$68.48 - $81.09 $12,189 - $14,434	178 Added 4.4%	4,228 $0
Q3 2022 Oct 25, 2022	BUY	$0.13 - $76.84 $158 - $93,975	1,223 Added 43.26%	4,050 $288,000
Q2 2022 Jul 15, 2022	BUY	$72.62 - $79.98 $105,662 - $116,370	1,455 Added 106.05%	2,827 $218,000
Q1 2022 Apr 21, 2022	BUY	$61.48 - $73.72 $25,329 - $30,372	412 Added 42.92%	1,372 $100,000
Q4 2021 Jan 20, 2022	BUY	$53.63 - $62.52 $3,593 - $4,188	67 Added 7.5%	960 $60,000
Q3 2021 Oct 28, 2021	BUY	$59.17 - $69.31 $52,838 - $61,893	893 New	893 $53,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Destiny Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Destiny Wealth Partners, LLC with notifications on news.